FDA authorizes new monkeypox point-of-care test, updates COVID-19 medical device shortages

The Food and Drug Administration Friday authorized for emergency use a molecular test to detect mpox (formerly known as monkeypox) at the point of care in lesion swab specimens from individuals whose health care provider suspects they have the virus. 
 
In other news, FDA last week updated its list of medical device shortages and discontinued medical devices during the COVID-19 public health emergency.